Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)

ClinicalTrials.gov ID: NCT02973789

Public ClinicalTrials.gov record NCT02973789. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 6:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

LUNAR: Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study is a prospective, randomized controlled phase III trial aimed to test the efficacy and safety of TTFields, using the NovoTTF-200T device, concurrent with standard therapies for stage 4 NSCLC patients, following progression while on or after platinum based treatment. The device is an experimental, portable, battery operated device for chronic administration of alternating electric fields (termed TTFields or TTF) to the region of the malignant tumor, by means of surface, insulated electrode arrays.

Study identification

NCT ID
NCT02973789
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
NovoCure GmbH
Industry
Enrollment
291 participants

Conditions and interventions

Eligibility (public fields only)

Age range
22 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2016
Primary completion
Sep 23, 2024
Completion
Oct 8, 2024
Last update posted
Mar 17, 2026

2016 – 2024

United States locations

U.S. sites
73
U.S. states
30
U.S. cities
62
Facility City State ZIP Site status
Central Alabama Research Birmingham Alabama 35209
Ironwood Cancer & Research Center Chandler Arizona 85224
Cancer Center at St. Joseph Hospital and Medical Center Phoenix Arizona 85004
Beverly Hills Cancer Center Beverly Hills California 90211
California Cancer Associates for Research and Excellence, Inc. cCARE Fresno California 93720
St. Joseph Heritage Healthcare Fullerton California 92835
Saddleback Memorial Medical Center Laguna Hills California 92653
Redlands Community Hospital (Emad Ibrahim, MD, Inc.) Redlands California 92373
Dignity Health - Mercy Cancer Centers Sacramento California 95186
Sutter Institute for Medical Research Sacramento California 95816
Innovative Clinical Research Institute Whittier California 90603
Banner MD Anderson Cancer Center at North Colorado Medical Center Greeley Colorado 80631
Associated Neurologists of Southern CT, P.C. Fairfield Connecticut 06824
Washington Cancer Institute at MedStar Washington Hospital Center Washington D.C. District of Columbia 20010
GenesisCare USA Jacksonville Florida 32204
Miami Cancer Institute Miami Florida 33176
Mount Sinai Medical Center Miami Beach Florida 33140
AdventHealth Orlando Orlando Florida 32804
Adult Oncology Research Orlando Florida 32806
BRCR Medical Center INC Plantation Florida
University of Illinois Cancer Center Chicago Illinois 60612
Illinois CancerCare, P.C. Peoria Illinois 61615
Southern Illinois University, School of Medicine, Simmons Cancer Institute at SIU Springfield Illinois 62702
Franciscan Health Indianapolis Indianapolis Indiana 46237
University of Kansas Cancer Center Westwood Kansas 66205
Norton Cancer Institute Louisville Kentucky 40202
University Medical Center, Inc; DBA University of Louisville Louisville Kentucky 40202
LSU Health Sciences Center -New Orleans New Orleans Louisiana 70112
Tulane Cancer Center New Orleans Louisiana 70112
CHRISTUS Health Shreveport Louisiana 71105
Central Maine Medical Center Lewiston Maine
University of Maryland School of Medicine Baltimore Maryland 21201
Tufts Medical Center, Division of Hematology and Oncology Boston Massachusetts 02111
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Karmanos Cancer Institute Detroit Michigan 48201
Clinical Oncology Associates Farmington Hills Michigan 48336
Detroit Clinical Research Center Farmington Hills Michigan 48336
Saint Joseph Mercy Health System Ypsilanti Michigan 48197
HealthPartners Institute, Regions Cancer Care Center Saint Paul Minnesota 55101
Saint Luke's Cancer Institute Kansas City Missouri 64111
Washington University School of Medicine St Louis Missouri 63110
CHI Health Research Center Omaha Nebraska 68124
Oncology Hematology West, PC dba Nebraska Cancer Specialists Omaha Nebraska 68130
University of Nebraska Medical Center Omaha Nebraska
OptumCare Cancer Care Las Vegas Nevada 89102
Renown Regional Medical Center Institute for Cancer Reno Nevada 89502
Presbyterian Cancer Center Albuquerque New Mexico 87110
New York-Presbyterian/Queens Radiation Oncology Flushing New York 11355
Northern Westchester Hospital Mount Kisco New York 10549-3417
Stony Brook Cancer Center Stony Brook New York 11794
Oncology Specialists of Charlotte Charlotte North Carolina 28204
W.G. Bill Hefner VA Med Center Salisbury North Carolina 28144
Piedmont Radiation Oncology, PA Winston-Salem North Carolina 27103
Summa Health Akron Ohio 44304
Toledo Clinic Cancer Center Toledo Ohio 43623
Vita Medical Associates, P.C. Bethlehem Pennsylvania 18015
Geisinger Cancer Institute Danville Pennsylvania 17822
UT/Erlanger Oncology & Hematology Chattanooga Tennessee 37403
Texas Oncology - Amarillo Amarillo Texas 79106
Texas Oncology - Arlington Arlington Texas 76012
Christus Health Spohn Ministry Corpus Christi Texas 78404
Dallas VA Medical Center Dallas Texas 75216
Texas Oncology- Baylor Charles A. Sammons Cancer Center Dallas Texas 75246
The University of Texas Southwestern Medical Center Dallas Texas 75390
Oncology Consultants, P.A. Houston Texas 77030
Texas Oncology-McKinney McKinney Texas 75071
Texas Oncology - Paris Paris Texas 75460
Texas Oncology- Plano West Plano Texas 75093
Baylor Scott & White Health/McClinton Cancer Center Waco Texas 76712
Texas Oncology-Waco Waco Texas 76712
Huntsman Cancer Institute/University of Utah Salt Lake City Utah 84112
Overlake Medical Center & Clinics Bellevue Washington 98004
UW Carbone Cancer Center Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 51 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02973789, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 17, 2026 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02973789 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →